Abstract
Antigen presentation to T lymphocytes is the seminal triggering event of the specific immune response, and poxviruses encode immunomodulatory genes that disrupt this process. Discovery of viral proteins that interfere with steps in the antigen presentation process requires a robust, easily manipulated antigen-presenting and T lymphocyte response system. Use of fresh primary antigen-presenting cells (APC) is preferable because cell lines that can present antigen in vitro are often not representative of APC in vivo and are typically weak stimulators. To study immunomodulatory poxvirus genes, we have used infected primary rat macrophages to present a model antigen, the myelin basic protein peptide, to a cognate CD4+ RsL11 T cell clone. Using this system, viruses can be assessed for difference in immunomodulation, and viral gene functions may also be assayed by comparing effects of wild type virus and mutant viruses (e.g., a deletion in the putative immunomodulatory gene). While antigen presentation can be thought of as a single event, it can also be considered as a larger process comprising multiple steps including: antigen acquisition, antigen processing, peptide loading onto MHC molecules, transport to the surface, MHC binding to T cell receptor, interaction of costimulatory molecules, cell signaling, cytokine synthesis by both cells, and proliferation of antigen specific T lymphocytes. This system allows for the initial determination of whether there is a phenotype and then also allows the stepwise deconstruction of the system to analyze this process at several points to focus in on the mechanism of immunomodulation. We have used this model system to elucidate the function of a highly conserved but previously uncharacterized poxvirus gene that we showed was important for virulence in rodents. The experimental system developed should be broadly applicable to analyzing viral effects on immunity.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Upton C, Slack S, Hunter AL, Ehlers A, Roper RL (2003) Poxvirus orthologous cluster: toward defining the minimum essential poxvirus genome. J Virol 77:7590–7600
Ludwig H, Mages J, Staib C, Lehmann MH, Lang R, Sutter G (2005) Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa cells: regulation of the virus life cycle and identification of differentially expressed host genes. J Virol 79:2584–2596
Guo ZS, Naik A, O’Malley ME, Popovic P, Demarco R, Hu Y et al (2005) The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2. Cancer Res 65:9991–9998
Bradley RR, Terajima M (2005) Vaccinia virus K1L protein mediates host-range function in RK-13 cells via ankyrin repeat and may interact with a cellular GTPase-activating protein. Virus Res 114:104–112
Langland JO, Jacobs BL (2002) The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range. Virology 299:133–141
Johnston JB, Barrett JW, Nazarian SH, Goodwin M, Ricuttio D, Wang G et al (2005) A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection. Immunity 23:587–598
Jackson SS, Ilyinskii P, Philippon V, Gritz L, Yafal AG, Zinnack K et al (2005) Role of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus. J Virol 79:6554–6559
Rehm KE, Connor RF, Jones GJB, Yimbu K, Mannie MD, Roper RL (2009) Vaccinia virus decreases MHC class II antigen presentation, T cell priming, and peptide association with MHC class II. Immunology 128:381–392
Rehm KE, Jones GJ, Tripp AA, Metcalf MW, Roper RL (2010) The poxvirus A35 protein is an immunoregulator. J Virol 84:418–425
Stewart TL, Wasilenko ST, Barry M (2005) Vaccinia virus F1L protein is a tail-anchored protein that functions at the mitochondria to inhibit apoptosis. J Virol 79:1084–1098
Gomez CE, Vandermeeren AM, Garcia MA, Domingo-Gil E, Esteban M (2005) Involvement of PKR and RNase L in translational control and induction of apoptosis after Hepatitis C polyprotein expression from a vaccinia virus recombinant. Virol J 2:81
Wang G, Barrett JW, Nazarian SH, Everett H, Gao X, Bleackley C et al (2004) Myxoma virus M11L prevents apoptosis through constitutive interaction with Bak. J Virol 78:7097–7111
Roper RL, Payne LG, Moss B (1996) Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene. J Virol 70:3753–3762
Roper RL, Wolffe EJ, Weisberg A, Moss B (1998) The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus. J Virol 72:4192–4204
Nichols DB, Shisler JL (2006) The MC160 protein expressed by the dermatotropic poxvirus molluscum contagiosum virus prevents tumor necrosis factor alpha-induced NF-kappaB activation via inhibition of I kappa kinase complex formation. J Virol 80:578–586
Shisler JL, Jin XL (2004) The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation. J Virol 78:3553–3560
Guerra S, Lopez-Fernandez LA, Conde R, Pascual-Montano A, Harshman K, Esteban M (2004) Microarray analysis reveals characteristic changes of host cell gene expression in response to attenuated modified vaccinia virus Ankara infection of human HeLa cells. J Virol 78:5820–5834
Rubins KH, Hensley LE, Jahrling PB, Whitney AR, Geisbert TW, Huggins JW et al (2004) The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model. Proc Natl Acad Sci USA 101:15190–15195
Wyatt LS, Earl PL, Eller LA, Moss B (2004) Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge. Proc Natl Acad Sci USA 101:4590–4595
Roper RL (2006) Characterization of the vaccinia virus A35R protein and its role in virulence. J Virol 80:306–313
Martina BE, van Doornum G, Dorrestein GM, Niesters HG, Stittelaar KJ, Wolters MA et al (2006) Cowpox virus transmission from rats to monkeys, the Netherlands. Emerg Infect Dis 12:1005–1007
Rehm KE, Connor RF, Jones GJ, Yimbu K, Roper RL (2010) Vaccinia virus A35R inhibits MHC class II antigen presentation. Virology 397:176–186
Mannie MD, Dawkins JG, Walker MR, Clayson BA, Patel DM (2004) MHC class II biosynthesis by activated rat CD4+ T cells: development of repression in vitro and modulation by APC-derived signals. Cell Immunol 230:33–43
Mannie MD, Norris MS (2001) MHC class-II-restricted antigen presentation by myelin basic protein-specific CD4+ T cells causes prolonged desensitization and outgrowth of CD4-responders. Cell Immunol 212:51–62
Campos-Neto A, Ovendale P, Bement T, Koppi TA, Fanslow WC, Rossi MA et al (1998) CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis. J Immunol 160:2037–2041
Li P, Wang N, Zhou D, Yee CS, Chang CH, Brutkiewicz RR et al (2005) Disruption of MHC class II-restricted antigen presentation by vaccinia virus. J Immunol 175:6481–6488
Chahroudi A, Chavan R, Koyzr N, Waller EK, Silvestri G, Feinberg MB (2005) Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor. J Virol 79:10397–10407
Acknowledgments
The author wishes to thank Dr. Mark Mannie, East Carolina University, for developing the rat antigen presentation system and for his generous help and advice. This work was supported by The North Carolina Biotechnology Center and NIH grant U54 AI057157 from Southeast Regional Center of Excellence for Emerging Infections and Biodefense.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Roper, R.L. (2012). Antigen Presentation Assays to Investigate Uncharacterized Immunoregulatory Genes. In: Isaacs, S. (eds) Vaccinia Virus and Poxvirology. Methods in Molecular Biology, vol 890. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-876-4_15
Download citation
DOI: https://doi.org/10.1007/978-1-61779-876-4_15
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-875-7
Online ISBN: 978-1-61779-876-4
eBook Packages: Springer Protocols